Group One Trading
FOLD

Group One Trading’s Amicus Therapeutics FOLD Stock Holding History

Group One Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Sell
7,861
-5,608
-42% -$80.4K ﹤0.01% 4614
2025
Q4 		$192K Sell
13,469
-29,680
-69% -$292K ﹤0.01% 4409
2025
Q3 		$340K Buy
43,149
+22,714
+111% +$162K ﹤0.01% 4097
2025
Q2 		$117K Buy
20,435
+4,806
+31% +$31K ﹤0.01% 4841
2025
Q1 		$128K Buy
+15,629
New +$145K ﹤0.01% 4417
2024
Q1 		– Sell
-33,514
Closed -$429K – 7321
2023
Q4 		$476K Buy
33,514
+20,285
+153% +$230K ﹤0.01% 3120
2023
Q3 		$161K Buy
+13,229
New +$171K ﹤0.01% 3995
2023
Q1 		– Sell
-124,051
Closed -$1.53M – 7435
2022
Q4 		$1.51M Buy
124,051
+18,363
+17% +$207K ﹤0.01% 2068
2022
Q3 		$1.1M Sell
105,688
-19,222
-15% -$214K ﹤0.01% 2482
2022
Q2 		$1.34M Sell
124,910
-47,325
-27% -$390K ﹤0.01% 2449
2022
Q1 		$1.63M Buy
172,235
+30,267
+21% +$284K ﹤0.01% 2602
2021
Q4 		$1.64M Buy
141,968
+2,556
+2% +$28.5K ﹤0.01% 2822
2021
Q3 		$1.33M Sell
139,412
-12,394
-8% -$127K ﹤0.01% 3094
2021
Q2 		$1.46M Sell
151,806
-137,036
-47% -$1.34M ﹤0.01% 2970
2021
Q1 		$2.85M Buy
288,842
+199,876
+225% +$3.09M ﹤0.01% 2089
2020
Q4 		$2.05M Sell
88,966
-8,887
-9% -$182K ﹤0.01% 2025
2020
Q3 		$1.38M Buy
+97,853
New +$1.43M ﹤0.01% 1903
2020
Q2 		– Sell
-88,999
Closed -$1.08M – 5895
2020
Q1 		$822K Buy
88,999
+58,919
+196% +$560K 0.01% 1673
2019
Q4 		$293K Buy
30,080
+22,168
+280% +$203K ﹤0.01% 2882
2019
Q3 		$63K Buy
7,912
+1,089
+16% +$11.8K ﹤0.01% 3867
2019
Q2 		$85K Buy
+6,823
New +$86.6K ﹤0.01% 3477
2019
Q1 		– Sell
-56,152
Closed -$686K – 4985
2018
Q4 		$538K Buy
56,152
+49,145
+701% +$540K ﹤0.01% 1947
2018
Q3 		$85K Sell
7,007
-58,677
-89% -$821K ﹤0.01% 3637
2018
Q2 		$1.03M Sell
65,684
-67,233
-51% -$1.02M 0.01% 1700
2018
Q1 		$2M Sell
132,917
-18,278
-12% -$278K 0.02% 1013
2017
Q4 		$2.18M Sell
151,195
-130,135
-46% -$1.79M 0.02% 1142
2017
Q3 		$4.24M Buy
+281,330
New +$3.72M 0.04% 593
2017
Q1 		– Sell
-357,131
Closed -$2.26M – 4742
2016
Q4 		$1.77M Buy
+357,131
New +$2.47M 0.02% 981
2016
Q1 		– Sell
-404,791
Closed -$2.87M – 4679
2015
Q4 		$3.93M Buy
404,791
+264,878
+189% +$2.39M 0.05% 474
2015
Q3 		$1.96M Buy
+139,913
New +$2.19M 0.03% 798
2015
Q1 		– Sell
-235,756
Closed -$2.08M – 4900
2014
Q4 		$1.96M Buy
235,756
+66,621
+39% +$457K 0.03% 653
2014
Q3 		$1.01M Buy
169,135
+78,546
+87% +$412K 0.02% 1117
2014
Q2 		$303K Buy
90,589
+74,754
+472% +$175K ﹤0.01% 2043
2014
Q1 		$33K Sell
15,835
-528
-3% -$1.32K ﹤0.01% 3925
2013
Q4 		$38K Buy
16,363
+4,413
+37% +$9.69K ﹤0.01% 3826
2013
Q3 		$28K Sell
11,950
-64,193
-84% -$161K ﹤0.01% 3954
2013
Q2 		$177K Buy
+76,143
New +$234K ﹤0.01% 2295

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Group One Trading's FOLD Position: Q1 2026 in Review

Group One Trading reduced its Amicus Therapeutics (FOLD) stake by 42% in Q1 2026, selling an estimated $80.4K and leaving 7,861 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4614.

Group One Trading first reported a position in FOLD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.24M in Q3 2017. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Group One Trading held 7,861 shares of Amicus Therapeutics worth $114K as of Q1 2026.
  • Group One Trading sold 5,608 Amicus Therapeutics shares in Q1 2026, an estimated $80.4K.
  • Amicus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4614 holding.
  • Group One Trading first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 37 quarters since.
  • Group One Trading's Amicus Therapeutics position peaked at $4.24M in Q3 2017.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.